|By PR Newswire||
|August 5, 2014 07:02 AM EDT||
THE WOODLANDS, Texas, Aug. 5, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will release its second quarter 2014 financial results on Thursday, August 7, 2014 before the financial markets open. Lexicon management will hold a conference call and webcast to discuss clinical development progress and financial results for the second quarter 2014 at 11:00 a.m. Eastern Time on August 7, 2014.
The dial-in number for the conference call is 888-645-5785 (within the US/Canada) or 970-300-1531 (international). The conference ID for all callers is 82427776. Investors can access a live webcast of the call at www.lexpharma.com. An archived version of the webcast will be available on the website through September 7, 2014.
Lexicon is a biopharmaceutical company focused on developing breakthrough treatments for human disease. Lexicon has clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. For additional information about Lexicon and its programs, please visit www.lexpharma.com.
Safe Harbor Statement
This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to meet its capital requirements, successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Lexicon Pharmaceuticals, Inc.
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Dec. 2, 2016 01:15 PM EST Reads: 2,064
Dec. 2, 2016 01:00 PM EST Reads: 1,373
Dec. 2, 2016 01:00 PM EST Reads: 2,436
Dec. 2, 2016 12:11 PM EST Reads: 150
Dec. 2, 2016 12:00 PM EST Reads: 1,823
Dec. 2, 2016 12:00 PM EST Reads: 129
Dec. 2, 2016 11:45 AM EST Reads: 1,451
Dec. 2, 2016 11:30 AM EST Reads: 1,842
Dec. 2, 2016 11:30 AM EST Reads: 3,737
Dec. 2, 2016 11:00 AM EST Reads: 394
Dec. 2, 2016 11:00 AM EST Reads: 393
Dec. 2, 2016 10:45 AM EST Reads: 1,591
Dec. 2, 2016 10:30 AM EST Reads: 1,897
Dec. 2, 2016 10:15 AM EST Reads: 2,021
As ridesharing competitors and enhanced services increase, notable changes are occurring in the transportation model. Despite the cost-effective means and flexibility of ridesharing, both drivers and users will need to be aware of the connected environment and how it will impact the ridesharing experience. In his session at @ThingsExpo, Timothy Evavold, Executive Director Automotive at Covisint, discussed key challenges and solutions to powering a ride sharing and/or multimodal model in the age ...
Dec. 2, 2016 10:00 AM EST Reads: 1,069